HighTower Advisors’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.6K | Sell |
|
|||||
|
2025
Q1 | $13.1K | Sell |
|
|||||
|
2024
Q4 | $25.3K | Sell |
|
|||||
|
2024
Q3 | $26K | Sell |
|
|||||
|
2024
Q2 | $32K | Sell |
|
|||||
|
2024
Q1 | $165K | Sell |
|
|||||
|
2023
Q4 | $458K | Sell |
|
|||||
|
2023
Q3 | $601K | Sell |
|
|||||
|
2023
Q2 | $1.04M | Sell |
|
|||||
|
2023
Q1 | $1.04M | Buy |
|
|||||
|
2022
Q4 | $708K | Sell |
|
|||||
|
2022
Q3 | $630K | Sell |
|
|||||
|
2022
Q2 | $703K | Sell |
|
|||||
|
2022
Q1 | $1.9M | Buy |
|
|||||
|
2021
Q4 | $1.86M | Buy |
|
|||||
|
2021
Q3 | $2.08M | Sell |
|
|||||
|
2021
Q2 | $2.88M | Sell |
|
|||||
|
2021
Q1 | $3.09M | Buy |
|
|||||
|
2020
Q4 | $371K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $101K | Buy |
|
|||||
|
2017
Q1 | $94K | Buy |
|